SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Anal Cancer
Related studies linked through entity extraction aliases.
Blood Biomarkers Based Screening for HPV-driven OPC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
- Status
- RECRUITING
- Phase
- NA
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Stigma and Psychological profilE in REctal-anal caNcer pAtients
- Status
- RECRUITING
- Phase
- N/A
CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
- Status
- RECRUITING
- Phase
- N/A
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Status
- RECRUITING
- Phase
- NA
Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
- Status
- RECRUITING
- Phase
- PHASE3
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
- Status
- COMPLETED
- Phase
- NA
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1
A Study Regarding Tissue Response During and After Treatment for Anal Cancer
- Status
- RECRUITING
- Phase
- N/A
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Anal Cancer Risk In Women
- Status
- UNKNOWN
- Phase
- N/A
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Status
- RECRUITING
- Phase
- PHASE2
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2